Wells Fargo’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-111,000
| Closed | -$5.99M | – | 7200 |
|
|
2025
Q4 | $5.99M | Buy |
+111,000
| New | +$5.34M | ﹤0.01% | 2501 |
|
|
2025
Q1 | – | Sell |
-250,000
| Closed | -$14.1M | – | 7047 |
|
|
2024
Q4 | $14.1M | Hold |
250,000
| – | – | ﹤0.01% | 1596 |
|
|
2024
Q3 | $12.9M | Buy |
250,000
+150,000
| +150% | +$7.04M | ﹤0.01% | 1619 |
|
|
2024
Q2 | $4.15M | Sell |
100,000
-911,100
| -90% | -$40.8M | ﹤0.01% | 2401 |
|
|
2024
Q1 | $54.8M | Sell |
1,011,100
-201,500
| -17% | -$10.3M | 0.01% | 719 |
|
|
2023
Q4 | $62.2M | Buy |
1,212,600
+100,000
| +9% | +$5.25M | 0.02% | 648 |
|
|
2023
Q3 | $64.6M | Buy |
1,112,600
+401,100
| +56% | +$24.6M | 0.02% | 580 |
|
|
2023
Q2 | $45.5M | Buy |
711,500
+142,200
| +25% | +$9.54M | 0.01% | 739 |
|
|
2023
Q1 | $39.5M | Sell |
569,300
-400,400
| -41% | -$28.2M | 0.01% | 781 |
|
|
2022
Q4 | $69.8M | Buy |
969,700
+1,500
| +0.2% | +$113K | 0.02% | 552 |
|
|
2022
Q3 | $68.8M | Sell |
968,200
-71,000
| -7% | -$5.15M | 0.02% | 522 |
|
|
2022
Q2 | $80M | Buy |
1,039,200
+69,200
| +7% | +$5.27M | 0.02% | 493 |
|
|
2022
Q1 | $70.8M | Sell |
970,000
-13,400
| -1% | -$900K | 0.02% | 624 |
|
|
2021
Q4 | $61.3M | Sell |
983,400
-24,100
| -2% | -$1.41M | 0.02% | 694 |
|
|
2021
Q3 | $59.6M | Buy |
1,007,500
+8,900
| +0.9% | +$586K | 0.01% | 947 |
|
|
2021
Q2 | $66.7M | Sell |
998,600
-198,600
| -17% | -$12.9M | 0.01% | 892 |
|
|
2021
Q1 | $75.6M | Buy |
1,197,200
+468,600
| +64% | +$29.2M | 0.02% | 825 |
|
|
2020
Q4 | $3.75M | Sell |
728,600
-290,800
| -29% | -$17.9M | ﹤0.01% | 2995 |
|
|
2020
Q3 | $3.42M | Buy |
1,019,400
+65,800
| +7% | +$3.96M | ﹤0.01% | 2857 |
|
|
2020
Q2 | $3.74M | Buy |
953,600
+595,000
| +166% | +$35.6M | ﹤0.01% | 2753 |
|
|
2020
Q1 | $1.19M | Sell |
358,600
-96,400
| -21% | -$5.89M | ﹤0.01% | 3427 |
|
|
2019
Q4 | $3.43M | Buy |
455,000
+265,400
| +140% | +$15.2M | ﹤0.01% | 2891 |
|
|
2019
Q3 | $324K | Hold |
189,600
| – | – | ﹤0.01% | 4668 |
|
|
2019
Q2 | $171K | Buy |
+189,600
| New | +$8.83M | ﹤0.01% | 5056 |
|
|
2019
Q1 | – | Sell |
-140,600
| Closed | -$1.36M | – | 6052 |
|
|
2018
Q4 | $1.36M | Buy |
140,600
+115,600
| +462% | +$6.21M | ﹤0.01% | 3603 |
|
|
2018
Q3 | $189K | Buy |
+25,000
| New | +$1.48M | ﹤0.01% | 5037 |
|
|
2018
Q2 | – | Sell |
-10,200
| Closed | -$10K | – | 6326 |
|
|
2018
Q1 | $10K | Sell |
10,200
-221,800
| -96% | -$14.3M | ﹤0.01% | 5942 |
|
|
2017
Q4 | $112K | Buy |
232,000
+228,600
| +6,724% | +$14.3M | ﹤0.01% | 5256 |
|
|
2017
Q3 | $47K | Hold |
3,400
| – | – | ﹤0.01% | 5485 |
|
|
2017
Q2 | $24K | Hold |
3,400
| – | – | ﹤0.01% | 5588 |
|
|
2017
Q1 | $24K | Sell |
3,400
-46,600
| -93% | -$2.56M | ﹤0.01% | 5663 |
|
|
2016
Q4 | $29K | Buy |
+50,000
| New | +$2.73M | ﹤0.01% | 5532 |
|
|
2016
Q2 | – | Sell |
-50,000
| Closed | -$32K | – | 6101 |
|
|
2016
Q1 | $32K | Buy |
+50,000
| New | +$3.15M | ﹤0.01% | 5376 |
|
|
2014
Q3 | – | Sell |
-64,700
| Closed | -$8K | – | 6171 |
|
|
2014
Q2 | $8K | Buy |
+64,700
| New | +$3.19M | ﹤0.01% | 5686 |
|
Other funds holding BMY
VCM
VPM
Wells Fargo's BMY Position: Q1 2026 in Review
Wells Fargo increased its Bristol-Myers Squibb (BMY) stake by 0.12% in Q1 2026, buying an estimated $422K and bringing the position to 5,946,447 shares worth $361M. The position accounts for 0.07% of the portfolio, ranked #250.
Wells Fargo first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.07B in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wells Fargo held 5,946,447 shares of Bristol-Myers Squibb worth $361M as of Q1 2026.
- Wells Fargo bought 7,244 Bristol-Myers Squibb shares in Q1 2026, an estimated $422K.
- Bristol-Myers Squibb made up 0.07% of Wells Fargo's portfolio in Q1 2026, its #250 holding.
- Wells Fargo first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Bristol-Myers Squibb position peaked at $1.07B in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.